NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William P. QuinnCEO;CFO;Pres2026-09-189,132$3.24
$29.55kSell
Sarah NemecPAO;VP2026-09-184,077$3.24
$13.19kSell
Grant YonehiroCOO2026-09-186,850$3.24
$22.17kSell
Sarah NemecPAO;VP2026-09-172,922$3.32
$9.70kSell
William P. QuinnCEO;CFO;Pres2026-09-176,545$3.32
$21.72kSell
Grant YonehiroCOO2026-09-174,909$3.32
$16.29kSell
William P. QuinnCEO;CFO;Pres2026-09-161,889$3.77
$7.13kSell
Grant YonehiroCOO2026-09-161,417$3.77
$5.35kSell
Sarah NemecPAO;VP2026-09-16843$3.77
$3.18kSell
William P. QuinnCEO;CFO;Pres2026-06-05637$3.88
$2.47kBuy

1 of 2

BOLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital VIII LLC305.54%5,885,846$21.66MInsider
Holdings A. Novo192.28%3,703,991$13.63MInsider
Edgar Engleman170.96%3,293,286$12.12MInsider
James Healy142.99%2,754,437$10.14MInsider
Sofinnova Venture Partners X LP142.99%2,754,437$10.14MInsider
Mahendra Shah75.18%1,448,286$5.33MInsider
Edith A. Perez2.42%46,612$171.53kInsider
William P. Quinn1.32%25,384$93.41kInsider
Grant Yonehiro0.90%17,269$63.55kInsider
Sarah Nemec0.89%17,082$62.86kInsider

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT0.00%100.00%Net SellingNet Selling
ACXP0.00%48.81%
NRSN0.01%99.99%Net Buying
ENVB0.01%15.55%
SKYE0.00%100.00%Net SellingNet Selling

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 0.03% institutional shareholders, 1,036.31% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital VIII LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 305.54% of the company. Vivo Capital VIII LLC's Bolt Biotherapeutics shares are currently valued at $20.66M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.